Literature DB >> 9699516

Role of the I-domain in collagen binding specificity and activation of the integrins alpha1beta1 and alpha2beta1.

A Kern1, E E Marcantonio.   

Abstract

Adhesion to collagens by most cell types is mediated by the integrins alpha1beta1 and alpha2beta1. Both integrin alpha subunits belong to a group which is characterized by the presence of an I domain in the N-terminal half of the molecule, and this domain has been implicated in the ligand recognition. Since purified alpha1beta1 and alpha2beta1 differ in their binding to collagens I and IV and recognize different sites within the major cell binding domain of collagen IV, we investigated the potential role of the alpha1 and alpha2 I domains in specific collagen adhesion. We find that introducing the alpha2 I domain into alpha1 results in surface expression of a functional collagen receptor. The adhesion mediated by this chimeric receptor (alpha1-2-1beta1) is similar to the adhesion profile conferred by alpha2beta1, not alpha1beta1. The presence of alpha2 or alpha1-2-1 results in preferential binding to collagen I, whereas alpha1 expressing cells bind better to collagen IV. In addition, alpha1 containing cells bind to low amounts of a tryptic fragment of collagen IV, whereas alpha2 or alpha1-2-1 bearing cells adhere only to high concentrations of this substrate. We also find that collagen adhesion of NIH-3T3 mediated by alpha2beta1 or alpha1-2-1beta1, but not by alpha1, requires the presence of Mn2+ ions. This ion requirement was not found in CHO cells, implicating the I domain in cell type-specific activation of integrins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699516     DOI: 10.1002/(SICI)1097-4652(199809)176:3<634::AID-JCP20>3.0.CO;2-Y

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection.

Authors:  Jennifer L Taylor; Helle Bielefeldt-Ohmann; Ambra Pozzi; Angelo A Izzo
Journal:  Tuberculosis (Edinb)       Date:  2008-07-18       Impact factor: 3.131

2.  Induction of a VLA-2 (CD49b)-expressing effector T cell population by a cell-based neuroblastoma vaccine expressing CD137L.

Authors:  Xiaocai Yan; Bryon D Johnson; Rimas J Orentas
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy.

Authors:  A P Kvist; A Latvanlehto; M Sund; L Eklund; T Väisänen; P Hägg; R Sormunen; J Komulainen; R Fässler; T Pihlajaniemi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  Expression of the alpha1beta1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells.

Authors:  Itamar Goldstein; Shomron Ben-Horin; Jianfeng Li; Ilan Bank; Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

5.  Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.

Authors:  Tatjana Momic; Gadi Cohen; Reuven Reich; Franziska T Arlinghaus; Johannes A Eble; Cezary Marcinkiewicz; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2012-10-18       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.